Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Mol Med Rep ; 21(5): 2162-2170, 2020 05.
Artigo em Inglês | MEDLINE | ID: mdl-32323767

RESUMO

The formation and development of choroidal neovascularization (CNV) is accompanied by inflammation and fibrosis. Existing treatments are expensive and can cause irreversible complications. Pirfenidone (PFD) exerts anti­inflammatory and anti­fibrotic effects; however, its applications in the eye remain unclear. Male C57BL/6J mice (aged 6­8 weeks) were used to explore whether PFD can inhibit the formation of laser­induced CNV. The localization of transforming growth factor ß2 (TGFß2) was determined through immunofluorescent staining. After laser photocoagulation, the vehicle and PFD groups were intravitreally injected with 1 µl PBS and 1 µl 0.5% PFD, respectively. At day 7 after intravitreal injection, the expression of TGFß2 and vascular endothelial growth factor (VEGF) was assessed. Fundus fluorescein angiography was performed to investigate the extent of fluorescence leakage, and the CNV areas were analyzed using a choroidal flat mount. The results demonstrated that, on day 7 after photocoagulation, the expression of TGFß2 and VEGF was reduced in the experimental group. In addition, fluorescein angiography showed that the leakage area of CNV was significantly smaller in the PFD injection group than those observed in the control and vehicle groups. Moreover, the areas of CNV in the PFD injection group were smaller compared with those reported in the other two injection groups. Histopathological and TUNEL analyses performed on day 28 revealed that there were no notable abnormalities on the layers of the neural retina of PFD­treated mice. In conclusion, intravitreal injection of PFD inhibited the formation of CNV in mice, likely via the downregulation of VEGF and TGFß2, which did not cause damage to the mouse retina after 28 days of treatment.


Assuntos
Corioide/metabolismo , Neovascularização de Coroide/tratamento farmacológico , Neovascularização de Coroide/patologia , Piridonas/uso terapêutico , Retina/efeitos dos fármacos , Animais , Corioide/diagnóstico por imagem , Corioide/efeitos dos fármacos , Corioide/patologia , Neovascularização de Coroide/diagnóstico por imagem , Modelos Animais de Doenças , Angiofluoresceinografia , Imunofluorescência , Injeções Intravítreas , Lasers , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Retina/metabolismo , Retina/efeitos da radiação , Fator de Crescimento Transformador beta/metabolismo , Fator A de Crescimento do Endotélio Vascular/metabolismo
2.
Cell Reprogram ; 21(2): 108-114, 2019 04.
Artigo em Inglês | MEDLINE | ID: mdl-30969881

RESUMO

Berberine, a Chinese medical herbal extract, plays a key role in antidiabetic, antiangiogenesis, anti-inflammatory, antimicrobial, anticancer, and antihypercholesterolemic. Our previous studies revealed that berberine exerted odontoprotective effect by increasing odontoblast differentiation. However, the mechanisms involved in the odontoprotective effect of berberine have not been fully explored. The Wnt/ß-catenin pathway is involved in odontoblast differentiation of dental pulp stem cells (DPSCs). If ß-catenin is nuclear translocation, the Wnt/ß-catenin pathway is activation. In this study, DPSCs were treated with or without berberine. Then, we examined the accelerative effects of berberine on odontoblast differentiation and mineralized nodules formation by real-time polymerase chain reaction, alizarin red S staining, and alkaline phosphatase staining. In addition, while treated with berberine, ß-catenin translocated to the nucleus evaluated by western blot and immunofluorescent staining. Our results revealed that berberine functions as a promoter of odontoblast differentiation by promoting Wnt/ß-catenin pathway, suggesting that it may be useful in guiding therapeutic strategies for the treatment of dental caries.


Assuntos
Berberina/farmacologia , Diferenciação Celular/efeitos dos fármacos , Polpa Dentária/citologia , Regulação da Expressão Gênica/efeitos dos fármacos , Odontoblastos/citologia , Células-Tronco/citologia , Proteína Wnt1/metabolismo , beta Catenina/metabolismo , Adolescente , Adulto , Células Cultivadas , Polpa Dentária/efeitos dos fármacos , Polpa Dentária/metabolismo , Humanos , Odontoblastos/efeitos dos fármacos , Odontoblastos/metabolismo , Células-Tronco/efeitos dos fármacos , Células-Tronco/metabolismo , Proteína Wnt1/genética , Adulto Jovem , beta Catenina/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA